Ideal Power advances AI Data center and EV programs in Q2 2026

Ideal Power (IPWR) reported Q2 2026 progress commercializing its B-TRAN solid-state power technology for AI data centers, energy infrastructure, and EVs. It advanced an SSCB project with an Asian lead customer, shipped B-TRAN evaluation samples to Stellantis, and signed a long-term supply agreement with an Asian wafer foundry. Cash was $41.3M; net loss $3.4M.

Original reporting
Published Aug 13, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ideal Power advances AI Data center and EV programs in Q2 2026 — source image
Decision brief

The 30-second read

$IPWRBullishMed
01

Why it matters

The update combines (1) customer/prototype progress, (2) supply-chain progress (wafer foundry first silicon and long-term supply agreement), and (3) balance-sheet support (cash plus recent registered direct offering). The key trading question is whether these milestones translate into production orders with measurable revenue impact.

02

Market read

Traders may re-rate the probability of near-term commercialization as the company moves from evaluation samples and reference designs toward production qualification.

03

What to watch

Cash raised via registered direct offering may dilute; traders may discount progress until orders, unit economics, and qualification timelines are clearer.

Relevance 7/10Novelty 6/10Timing: Q2 results and commercialization updates reported after market close

Background

Ideal Power is commercializing its B-TRAN solid-state power technology via low-current solid-state circuit breakers (SSCBs) for AI data centers and EV power systems.

Company-level read

Ticker impact

$IPWRBullishMedium confidence
Context

Ideal Power says it advanced B-TRAN solid-state circuit breaker work with a lead Asian customer and shipped new evaluation samples to Stellantis for EVs.

Expected impact

Bias toward positive near-term sentiment, with follow-through likely tied to customer production order timing.

Evidence & confidence

The article provides multiple concrete commercialization datapoints (lead customer co-development, Stellantis shipments, reference design kit, wafer foundry first silicon, and a long-term supply agreement) but no revenue guidance or immediate order size.

Market effects

Supports the narrative of accelerating 800V DC power distribution adoption for AI data centers and EVs, potentially benefiting power-electronics supply chains.

Asian customer and wafer foundry involvement highlights ongoing Asia-based manufacturing and evaluation cycles for solid-state power components.

Hyperscaler-linked evaluation work (Rubin Ultra 800V DC architecture) ties the theme to global AI infrastructure buildouts.

Counterpoint

Milestones described are still largely evaluation and prototype oriented, so production-order timing and scale remain uncertain.

Key entities

  • Ideal Power

    Advancing B-TRAN-enabled SSCB programs for AI data centers and EV applications; reported Q2 cash position and commercialization milestones.

  • Stellantis

    Received a second shipment of next-generation B-TRAN evaluation samples for EV applications.

  • Coherent Corp.

    Chief Marketing Officer joined Ideal Power’s newly formed advisory board.

  • NVIDIA

    Rubin Ultra 800V DC AI data center power distribution architecture is referenced as the hyperscaler evaluation target.

Related articles

$IPWRMed

Ideal Power Inc. Q2 2026 Earnings Call Summary

Ideal Power Inc. reported Q2 2026 progress tied to 800-volt DC adoption in AI data centers. Its sales funnel rose to over $400 million. The company expects prototype B-TRAN-enabled SSCBs for 800-volt customers in Q4 2026, with initial low-volume orders then. 2026 cash burn is projected at $10.3M to $10.5M after a May $27.7M net raise.

$IPWRMed

Ideal Power signs foundry deal, advances B-TRAN customer projects in Q2

Ideal Power (NASDAQ:IPWR) said it advanced its B-TRAN bidirectional semiconductor switch in Q2, including prototype work with an Asian customer and an industry partner tied to Nvidia’s Rubin Ultra 800V DC data center architecture. It is shipping low-current SSCB prototypes to the lead customer, delivered EV samples to Stellantis, and signed a long-term wafer foundry supply deal. Q2 net loss was $3.4M; cash $41.3M.

$IPWRMed

Ideal Power Reports Second Quarter 2026 Financial Results

Ideal Power Inc. (Nasdaq: IPWR) reported Q2 2026 results for the quarter ended June 30, 2026. The company said it advanced B-TRAN®-enabled solid-state circuit breaker projects, including prototype shipments to an Asia lead customer and sample delivery to Stellantis. It entered a long-term wafer foundry supply deal and reported $41.3M cash, $27.7M net from a stock offering, and a $3.4M Q2 net loss.

$IPWRMed

Ideal Power Inc. (IPWR): Results of Operations and Financial Condition

Ideal Power Inc. (IPWR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1003688.htm EXHIBIT 99.1 ex_1003688.htm Exhibit 99.1 Ideal Power Reports Second Quarter 2026 Financial Results AUSTIN, TX – August 13, 2026 -- Ideal Power Inc. (Nasdaq: IPWR) (“Ideal Power,” the “Company,” “we,” “us” or “our”), developer and provider of its innovativ

$IPWRMedAI 8/10

Ideal Power Inc. (NASDAQ:IPWR) Short Interest Update

Ideal Power Inc. (NASDAQ:IPWR) saw short interest rise sharply in May, reaching 199,504 shares as of May 15, up 241.3% from 58,447 on April 30; short interest equals 1.6% of shares, with a days-to-cover ratio of 0.3. The article also notes a March 28 downgrade to “sell” and a $10.75 consensus price target.

$NTHIMed

Stonegate, Inc.: Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) 2Q26

Stonegate Capital Partners updated coverage of NeOnc Technologies Holdings (NASDAQ: NTHI), citing 2Q26 progress for NEO100 and NEO212. NEO100 Phase 2a reported PFS at 6 months of 48.9% vs a 20% benchmark (p=0.0047), median OS 26.09 months, and no major toxicities. NeOnc plans a Type B FDA meeting; R&D rose to $2.6M from $0.7M year over year.

Ideal Power advances AI Data center and EV programs in Q2 2026 — alphai